Open AccessIs there association of olanzapine and pulmonary embolism: A case report
Author(s) -
Wang Lumin,
Xu Yijiao,
Jiang Weiwen,
Liu Jiaxin,
Cao Chang,
Shen Yun,
Xiao Xiong,
Ye Yanrong
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5805
Subject(s) - medicine , olanzapine , pulmonary embolism , chest pain , cardiology , paranoid schizophrenia , radiology , anesthesia , surgery , schizophrenia (object oriented programming) , psychosis , psychiatry
Olanzapine is a second‐generation antipsychotic drug that is often used to treat schizophrenia and manic attacks. An increasing number of cases in recent years have shown that olanzapine is associated with vascular thromboembolic disease (VTD). Here, we reported a case of patient with history of taking aripiprazole, benzhexol, olanzapine, and sertraline for 5 years. He was admitted because of aggravated chest tightness, chest pain, and shortness of breath sustaining for 3 days. Laboratory examination and computed tomography angiography of the chest revealed new pulmonary embolus which involved the main trunk of the pulmonary artery and bilateral pulmonary arteries, with pneumonic infiltration in the left upper lobe. After thrombolytic therapy, the patient was out of danger.